Nuvalent, Inc. (NUVL)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Nuvalent, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Nuvalent, Inc. (NUVL) has returned 1.85% so far this year and 44.46% over the past 12 months.

Based on dividend-adjusted daily data since Jul 29, 2021, NUVL's average daily return is +0.25%, while the average monthly return is +5.03%. At this rate, your investment would double in approximately 1.2 years.

Historically, 60% of months were positive and 40% were negative. The best month was Aug 2021 with a return of +99.6%, while the worst month was Sep 2021 at -38.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 3 months.

On a daily basis, NUVL closed higher 50% of trading days. The best single day was Oct 28, 2022 with a return of +60.6%, while the worst single day was Mar 14, 2022 at -24.8%.

Nuvalent, Inc. has an annualized alpha of 62.38%, beta of 1.47, and R² of 0.11 versus S&P 500 Index. Calculated based on daily prices since July 30, 2021.

• This stock captured 316.28% of S&P 500 Index gains and 126.73% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.11 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NUVL ranks 73 for risk / return — better than 73% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Nuvalent, Inc. (NUVL) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Nuvalent, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Nuvalent, Inc. was 80.70%, occurring on May 16, 2022. Recovery took 240 trading sessions.

The current Nuvalent, Inc. drawdown is 8.67%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Nuvalent, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Nuvalent, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.